Fact CheckerSign in

NCT06039787Recruiting

Exercise Training on Brain Insulin Responsiveness

Effects of One Exercise Training Session on Brain Insulin Responsiveness

Source: ClinicalTrials.gov · Last updated 8 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The overarching goal of the current study is to investigate the effect of one acute bout of exercise on the brain insulin responsiveness in a cross-over study design. To this end, investigators will compare the effect of two single endurance exercise sessions with different intensities, namely moderate intensity continuous training (MICT) and high-intensity-interval-training (HIIT), which will be performed in a randomized order. This will be compared to a waiting control condition.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
6 Sept 2023
Start date
20 Oct 2023
Primary completion date
31 Dec 2026
Lead sponsor
University Hospital Tuebingen
Diseases
Obesity
NCT number
NCT06039787

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 20 Oct 2023 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Taking psychotropic drugs
  • Regular use of analgesic drugs
  • Previous bariatric surgery

Other illness

  • Type 2 diabetes, cardiovascular diseases such as chronic heart failure, myocardial infarction, status post stroke
  • Limitations to participate in ergometer-based exercise (balance and coordination disorders, orthopedic problems, …)
  • History of severe mental or somatic disorders including neurological diseases (incl. epileptic seizures and migraines)
  • Acute infection within the last 4 weeks
  • Other diseases that in the opinion of the investigator may jeopardize the success of the study or indicate a risk to the volunteer
  • Metal implants which cannot be removed as pacemakers, artificial heart valve, electrical devices as insulin pumps, large tattoos, retainer over more than 4 teeth, contraceptive coil, implanted magnetic metal parts as screws or plates after a surgery

Lab values

  • Taking medications that influence glucose metabolism
  • Hemoglobin values less than 12g/dl for women, less than 14 g/dl for men

Other

  • Insufficient knowledge of the German language
  • Persons who cannot legally give consent
  • Pregnancy or lactation
  • Taking anticoagulant agents
  • Current participation in a lifestyle intervention study or a pharmaceutical study
  • Persons with claustrophobia
  • Temperature-sensitive person
  • Persons with tinnitus or increased sensitivity to loud sounds

Who the study is looking for

  • BMI between ≥ 19.5 to 39 kg/m2-
  • Less than 150 min/week for moderate-intensity physical activity
  • Less than 75 min/week for Vigorous- intensity exercise (WHO recommendations for regular physical activity of adults)
  • Written consent to participate in the study
  • Written consent to be informed about incidental findings

Age in the registry: 20 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Clinic Tübingen, Department of Internal Medicine IV
Coordinator of this site? Confirm its status
TübingenGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.